|
Palo Alto, CA, July 29, 2004 – Telik, Inc. (Nasdaq:
TELK) announced that its quarterly conference call and webcast will
be held on Thursday, August 5, 2004 at 4:30 p.m. Eastern time (1:30
p.m. Pacific time). The call will follow the release of Telik’s
financial results for the second quarter ended June 30, 2004 earlier
that day.
Participants may access the live webcast via Telik’s website
at www.telik.com or by telephone
at 651-291-0900. A replay of the webcast will be available on the
Telik website from approximately 7:30 p.m. Eastern time on August
5 through August 12, 2004.
Telik, Inc. of Palo Alto, CA is a biopharmaceutical company working
to discover, develop and commercialize small molecule drugs to treat
serious diseases for which there is significant demand for new therapies.
The company’s most advanced drug development candidate is TELCYTA™.
Telik’s product candidates were discovered using its proprietary
technology, TRAP, which enables the rapid and efficient discovery
of small molecule drug candidates. Additional information is available
at www.telik.com.
###
Contact:
Carol DeGuzman
Senior Director, Corporate Communications
Telik, Inc.
Tel 650-845-7728
Email cdeguzman@telik.com
Go to: 2004
Press Releases2003
Press ReleasesEvents
|
